Genipin-Crosslinked Gelatin-Mediated Immobilization of Vancomycin/Rifampin Microspheres on 3D-Printed Porous Tantalum Scaffolds for Local Antibacterial Prophylaxis in Bone Repair
Abstract Implant-associated infections and insufficient osseointegration remain critical challenges in orthopedic surgery. This study developed a multifunctional scaffold by immobilizing vancomycin- and rifampin-loaded PLGA/PLLA core–shell microspheres onto 3D-printed porous tantalum (Ta) via a genipin-crosslinked gelatin coating. The composite scaffold (pTa-Gle@MS) exhibited a hierarchical porous architecture and achieved sustained, sequential dual-antibiotic release over 27 days in vitro , with an initial burst release followed by a gradual release phase. In vitro antibacterial assays against Staphylococcus aureus demonstrated that pTa-Gle@MS markedly reduced planktonic and adherent bacteria and inhibited biofilm formation, achieving a 95.1 ± 3.2% reduction in bacterial counts, whereas bare and gelatin-coated Ta showed no antimicrobial activity. Cytocompatibility and osteogenic differentiation assays in MC3T3-E1 cells revealed that the functionalized scaffold supported cell adhesion, proliferation, and osteogenesis comparably to unmodified porous Ta, with no significant differences in collagen secretion, ALP activity, mineralization, or osteogenic gene expression ( P > 0.05). In a non-infected rat femoral condyle defect model, pTa-Gle@MS maintained local therapeutic antibiotic concentrations at 6 weeks without detectable systemic accumulation in the liver or kidney and achieved new bone ingrowth and osseointegration at 12 weeks comparable to control scaffolds, as confirmed by micro-CT and histological analysis. These findings indicate that gelatin-mediated integration of antibiotic microspheres confers in vitro antibacterial and antibiofilm activity on 3D-printed porous Ta without compromising its inherent osteoconductivity. Further evaluation in infected or contaminated defect models is required to determine its in vivo infection-prevention efficacy.
Authors
- 王锡阳
- Guanghui Zhu (ORCID: https://orcid.org/0009-0005-8550-3364)
- Dingyu Jiang (ORCID: https://orcid.org/0000-0001-6353-0517)
- Zhenchao Xu
- Yilu Zhang
- Zheng Liu
Institutions
- Hunan Children's Hospital (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11567222/v1
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- preprint
Funders
- National Key Research and Development Program of China